E2F1 and osteosarcoma: While other studies have proposed that an increase in E2F1 expression could mediate the transcriptional repression of MCL-1 [29, 31], we were unable to detect changes in E2F1 protein levels upon flavopiridol treatment in osteosarcoma (Figure 2D).